免疫生物研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/01/28 | 6,400 | 7,280 | 6,310 | 7,200 | +920 | +14.6% | 122,160 |
| 2013/01/25 | 6,500 | 6,510 | 6,140 | 6,280 | -20 | -0.3% | 29,000 |
| 2013/01/24 | 6,010 | 6,320 | 6,000 | 6,300 | +320 | +5.4% | 27,680 |
| 2013/01/23 | 5,940 | 6,450 | 5,890 | 5,980 | +20 | +0.3% | 60,240 |
| 2013/01/22 | 6,000 | 6,000 | 5,850 | 5,960 | +60 | +1% | 5,880 |
| 2013/01/21 | 5,800 | 6,020 | 5,720 | 5,900 | ±0 | ±0% | 9,490 |
| 2013/01/18 | 6,100 | 6,100 | 5,880 | 5,900 | -100 | -1.7% | 8,610 |
| 2013/01/17 | 6,200 | 6,240 | 5,930 | 6,000 | -180 | -2.9% | 14,870 |
| 2013/01/16 | 6,450 | 6,460 | 6,100 | 6,180 | +30 | +0.5% | 32,280 |
| 2013/01/15 | 5,920 | 6,320 | 5,780 | 6,150 | +350 | +6% | 48,910 |
| 2013/01/11 | 6,130 | 6,130 | 5,650 | 5,800 | -300 | -4.9% | 31,180 |
| 2013/01/10 | 5,540 | 6,350 | 5,510 | 6,100 | +640 | +11.7% | 56,440 |
| 2013/01/09 | 5,490 | 5,500 | 5,380 | 5,460 | +10 | +0.2% | 7,260 |
| 2013/01/08 | 5,280 | 5,460 | 5,280 | 5,450 | +190 | +3.6% | 8,950 |
| 2013/01/07 | 5,160 | 5,350 | 5,100 | 5,260 | +180 | +3.5% | 13,370 |
| 2013/01/04 | 4,950 | 5,090 | 4,910 | 5,080 | +155 | +3.1% | 6,710 |
| 2012/12/28 | 4,860 | 4,975 | 4,860 | 4,925 | -25 | -0.5% | 6,870 |
| 2012/12/27 | 5,060 | 5,150 | 4,940 | 4,950 | -100 | -2% | 12,050 |
| 2012/12/26 | 5,100 | 5,150 | 4,825 | 5,050 | -650 | -11.4% | 41,420 |
| 2012/12/25 | 5,690 | 5,720 | 5,600 | 5,700 | +70 | +1.2% | 6,970 |
| 2012/12/21 | 5,770 | 5,800 | 5,580 | 5,630 | -170 | -2.9% | 8,830 |
| 2012/12/20 | 5,720 | 6,000 | 5,720 | 5,800 | +80 | +1.4% | 7,030 |
| 2012/12/19 | 5,840 | 5,890 | 5,630 | 5,720 | -120 | -2.1% | 10,680 |
| 2012/12/18 | 6,000 | 6,080 | 5,820 | 5,840 | -260 | -4.3% | 14,390 |
| 2012/12/17 | 6,280 | 6,280 | 6,060 | 6,100 | -100 | -1.6% | 6,000 |
| 2012/12/14 | 6,130 | 6,380 | 6,100 | 6,200 | +60 | +1% | 12,430 |
| 2012/12/13 | 6,090 | 6,230 | 6,010 | 6,140 | +20 | +0.3% | 7,490 |
| 2012/12/12 | 6,180 | 6,200 | 6,070 | 6,120 | -50 | -0.8% | 4,720 |
| 2012/12/11 | 6,300 | 6,320 | 6,100 | 6,170 | -130 | -2.1% | 8,460 |
| 2012/12/10 | 6,400 | 6,490 | 6,250 | 6,300 | -70 | -1.1% | 6,990 |
| 2012/12/07 | 6,460 | 6,550 | 6,350 | 6,370 | -60 | -0.9% | 10,200 |
| 2012/12/06 | 6,540 | 6,600 | 6,350 | 6,430 | -120 | -1.8% | 10,600 |
| 2012/12/05 | 6,270 | 6,670 | 6,230 | 6,550 | +360 | +5.8% | 26,540 |
| 2012/12/04 | 6,070 | 6,230 | 6,040 | 6,190 | +110 | +1.8% | 6,650 |
| 2012/12/03 | 6,100 | 6,100 | 5,910 | 6,080 | -10 | -0.2% | 7,500 |
| 2012/11/30 | 6,220 | 6,230 | 5,950 | 6,090 | -110 | -1.8% | 16,950 |
| 2012/11/29 | 6,500 | 6,560 | 6,050 | 6,200 | -270 | -4.2% | 16,460 |
| 2012/11/28 | 6,800 | 6,800 | 6,390 | 6,470 | -130 | -2% | 14,770 |
| 2012/11/27 | 6,580 | 6,870 | 6,460 | 6,600 | +150 | +2.3% | 19,460 |
| 2012/11/26 | 6,800 | 7,140 | 6,450 | 6,450 | -170 | -2.6% | 52,060 |
| 2012/11/22 | 6,450 | 6,780 | 6,070 | 6,620 | +120 | +1.8% | 46,480 |
| 2012/11/21 | 5,790 | 6,560 | 5,790 | 6,500 | +740 | +12.8% | 47,600 |
| 2012/11/20 | 5,890 | 5,890 | 5,710 | 5,760 | -40 | -0.7% | 8,790 |
| 2012/11/19 | 5,850 | 5,850 | 5,740 | 5,800 | +110 | +1.9% | 8,880 |
| 2012/11/16 | 5,550 | 5,750 | 5,480 | 5,690 | +210 | +3.8% | 8,360 |
| 2012/11/15 | 5,420 | 5,500 | 5,250 | 5,480 | +60 | +1.1% | 6,700 |
| 2012/11/14 | 5,630 | 5,640 | 5,320 | 5,420 | -180 | -3.2% | 6,480 |
| 2012/11/13 | 5,680 | 5,720 | 5,430 | 5,600 | +20 | +0.4% | 10,790 |
| 2012/11/12 | 5,250 | 5,660 | 5,220 | 5,580 | +290 | +5.5% | 11,220 |
| 2012/11/09 | 5,410 | 5,420 | 5,250 | 5,290 | -190 | -3.5% | 6,760 |
3001～
3050
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「免疫生物」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 免疫生物 | 47,200円 | +13.4% | +44.0% | 0.00% | 20.45倍 | 3.29倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
| ＤＷＴＩ | 10,000円 | -15.1% | - | 0.00% | - | 6.18倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
| ＤＥＬＴＡ－Ｐ | 45,600円 | - | - | 0.00% | - | 14.13倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| ＶＩＳ | 66,100円 | +306.2% | - | 0.00% | 25.52倍 | 1.94倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| リボミック | 8,600円 | - | - | 0.00% | - | 1.17倍 |
|
東大発の創薬ベンチャー。ＲＮＡ（リボ核酸）を利用した分子標的薬（アプタマー医薬）を開発 |
市場注目の銘柄
チャート関連のコラム
